Literature DB >> 19541533

Immune therapy for age-related diseases.

Marc E Weksler1, Graham Pawelec, Claudio Franceschi.   

Abstract

Human aging is reaching epidemic proportions as life expectancy increases and birth rate decreases. These demographic trends have led to a sharp increase in the diseases of aging, and an understanding of immune senescence promises to limit the development and progression of these diseases. In this review, we discuss three of the most important diseases of aging: shingles, Alzheimer's disease and atherosclerotic cardiovascular disease. All of these diseases have significant immunological components in either their etiology and/or progression, suggesting that appropriate immune intervention could be used in their prevention or treatment. Indeed, recent clinical studies have already demonstrated that vaccination can reduce the incidence of shingles and might prove effective in patients with Alzheimer's disease and artherosclerotic cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541533     DOI: 10.1016/j.it.2009.03.011

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  15 in total

Review 1.  [Immunosenescence. Current status and molecular mechanisms].

Authors:  T Peters
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

2.  Antigen Receptor Specificity and Cell Location Influence the Diversification and Selection of the B-1a Cell Pool with Age.

Authors:  Naomi Tsuji; Thomas L Rothstein; Nichol E Holodick
Journal:  J Immunol       Date:  2020-06-19       Impact factor: 5.422

Review 3.  T cell senescence and cardiovascular diseases.

Authors:  Hee Tae Yu; Sungha Park; Eui-Cheol Shin; Won-Woo Lee
Journal:  Clin Exp Med       Date:  2015-07-19       Impact factor: 3.984

4.  Herpes zoster vaccine for the elderly: boosting immunity.

Authors:  Joel V Chua; Wilbur H Chen
Journal:  Aging health       Date:  2010-04-01

Review 5.  B cells in the aging immune system: time to consider B-1 cells.

Authors:  Nichol E Holodick; Thomas L Rothstein
Journal:  Ann N Y Acad Sci       Date:  2015-07-20       Impact factor: 5.691

6.  Sex Influences Age-Related Changes in Natural Antibodies and CD5+ B-1 Cells.

Authors:  Sarah E Webster; Brinda Ryali; Michael J Clemente; Naomi L Tsuji; Nichol E Holodick
Journal:  J Immunol       Date:  2022-03-07       Impact factor: 5.422

7.  Age-Related Decline in Natural IgM Function: Diversification and Selection of the B-1a Cell Pool with Age.

Authors:  Nichol E Holodick; Teresa Vizconde; Thomas J Hopkins; Thomas L Rothstein
Journal:  J Immunol       Date:  2016-04-20       Impact factor: 5.422

8.  Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.

Authors:  Jianping Wang; Nan Li; Jun Ma; Zhiqiang Gu; Lie Yu; Xiaojie Fu; Xi Liu; Jian Wang
Journal:  Brain Res       Date:  2016-01-25       Impact factor: 3.252

Review 9.  Understanding immunosenescence and its impact on vaccination of older adults.

Authors:  Jessica C Allen; Franklin R Toapanta; Wilbur Chen; Sharon M Tennant
Journal:  Vaccine       Date:  2020-11-21       Impact factor: 3.641

10.  Alzheimers disease: review of emerging treatment role for intravenous immunoglobulins.

Authors:  Rakez Kayed; George R Jackson; D Mark Estes; Alan D T Barrett
Journal:  J Cent Nerv Syst Dis       Date:  2011-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.